Citigroup’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-54,000
Closed -$2.07M 5704
2024
Q1
$2.07M Buy
+54,000
New +$2.62M ﹤0.01% 2410
2013
Q3
Sell
-40,000
Closed -$1.03M 6903
2013
Q2
$1.03M Buy
+40,000
New +$1.05M ﹤0.01% 2877

Other funds holding MED

Citigroup's MED Position: Q1 2026 in Review

Citigroup reduced its Medifast (MED) stake by 29% in Q1 2026, selling an estimated $16K and leaving 3,599 shares worth $36.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4645.

Citigroup first reported a position in MED in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.13M in Q2 2021. 111 funds tracked by Wall St. Rank hold MED as of Q1 2026.

  • Citigroup held 3,599 shares of Medifast worth $36.7K as of Q1 2026.
  • Citigroup sold 1,483 Medifast shares in Q1 2026, an estimated $16K.
  • Medifast made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #4645 holding.
  • Citigroup first reported a position in Medifast in Q2 2013 and has held it in 52 quarters since.
  • Citigroup's Medifast position peaked at $3.13M in Q2 2021.
  • 111 funds tracked by Wall St. Rank held Medifast as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.